Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE: 002755)
Health Care · Pharmaceuticals · CN
CN¥13.55
+7.54% today · -31.7% 1Y
Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE: 002755) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.87B and employs 799 people.
Over the last twelve months the share price has lost 31.7%, trading between 11.02 and 20.77.
Tweenvest scores Beijing Aosaikang Pharmaceutical Co., Ltd. across four factors: quality 71/100, value 20/100, growth 0/100, dividend 49/100. Its strongest factor is quality.
002755 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.87B
- Revenue (TTM)
- $241.82M
- P/E
- 64.56
- EPS
- 0.21
- Dividend yield
- 0.89%
- Beta (5Y)
- 0.06
- 52-week high
- CN¥20.77
- 52-week low
- CN¥11.02
- Avg volume (3M)
- —
- Shares outstanding
- 928.16M
- Employees
- 799
- Next earnings
- —
About Beijing Aosaikang Pharmaceutical Co., Ltd.
Operating within China, Beijing Aosaikang Pharmaceutical Co., Ltd. specializes in the research, development, production, and sale of pharmaceuticals, fine chemicals, and health products. Its diverse offerings include proton pump inhibitor injections, oncology medications, and active pharmaceutical ingredients (APIs), which are applied across key therapeutic areas like digestive disorders, cancer treatment, and infectious diseases. The company was founded in 2003 and is headquartered in Nanjing, China.
- ISIN
- CNE100001X92
- Founded
- 1996
- Listed since
- May 15, 2015
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shenzhen Hepalink Pharmaceutical Group Co., Ltd.SZSE: 002399 | $1.95B | CN¥9.85 | +2.82% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd.SZSE: 300573 | $1.94B | CN¥36.43 | +2.07% |
| PharmaBlock Sciences (Nanjing), Inc.SZSE: 300725 | $1.92B | CN¥55.35 | +6.28% |
| The United Laboratories International Holdings LimitedSEHK: 3933 | $1.91B | HK$7.61 | -0.13% |
| Trevi Therapeutics, Inc.NasdaqGM: TRVI | $1.87B | $13.14 | -0.30% |
| Inner Mongolia Furui Medical Science Co., Ltd.SZSE: 300049 | $1.85B | CN¥47.11 | +0.19% |
| Xeris Biopharma Holdings, Inc.NasdaqGS: XERS | $1.84B | $10.11 | +0.40% |
| PT Kalbe Farma Tbk.IDX: KLBF | $1.83B | Rp725.00 | -1.36% |
Figures last refreshed Oct 4, 2026.